fashion -WSS

fashion

author：comprehensive 2025-10-02 23:30:24 - browse：198

In the center, three researchers examine a DNA helix. Two people stand in the front, one puts an apple into a capsule containing vegetables, the other holds a check list while standing next to a pile of medicines. On the right side, a scientist injects into mitochondria while another takes notes. A person behind the duo looks at a projection of a brain. On the left side, a client looks at a heart projection from a device held by a robot — biotech coverage from STAT — Adobe

When it comes to bringing an experimental drug to market and selling it, Novo Nordisk, the maker of the weight loss drug Wegovy, is tops, according to a new analysis.

But if you want to invent lots of potential drugs that could eventually reach the market, you’d be far better off with Johnson & Johnson, Merck, or AstraZeneca.

The analysis, the 13th edition of the Pharmaceutical Innovation and Invention Index, was produced by the consultancy Idea Pharma and released Thursday at the STAT Breakthrough Summit in San Francisco.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： In the gardens at Boston Children's Hospital, families find sanctuary

leisure time

WSS

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

UHS says company favors patients whose insurance pays more

Democrats decry new health bill for going easy on private equity

The Bio Revolution is changing business and society

Clinicians often fail to acknowledge the pain caused by long Covid

The Bio Revolution is changing business and society

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

Bright Health sells Medicare Advantage business to Molina

How doctors’ personal politics affect patients

Guidelines to prevent youth baseball injuries need more muscle

Louisiana bill approved classifying abortion pills as controlled substances

Dobbs anniversary: the lost opportunity of abortion as health care

STAT Report: Patient voices and perspectives

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Biden warns of ‘dark winter’ during final presidental debate

Peter Hotez and the public health issue of online harassment

U.S. death rates show how politics are affecting public health

knowledge

Guardant Health colon cancer test endorsed by FDA advisory panel

A new crop of companies is reshaping the health data economy

UHS says company favors patients whose insurance pays more

U.S. death rates show how politics are affecting public health

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Unmasking the 'centricity' illusion in clinical trials

leisure time

focus

leisure time

hotspot